1,110 results on '"Emma, Francesco"'
Search Results
2. Childhood-onset IgA nephropathy: is long-term recovery possible?
3. A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance
4. Successful treatment with avacopan (CCX168) in a pediatric patient with C3 glomerulonephritis
5. Long-term effects of luteolin in a mouse model of nephropathic cystinosis
6. Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice
7. Steroid-Resistant Nephrotic Syndrome due to NPHS2 Variants Is Not Associated With Posttransplant Recurrence
8. The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data
9. XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
10. Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression
11. A pediatric case of IgA nephropathy benefitting from targeted release formulation–budesonide
12. Application of the updated International IgA Nephropathy Prediction Tool in children one or two years post-biopsy
13. Cystinosis
14. Pediatric Fanconi Syndrome
15. Renal Manifestations of Metabolic Disorders in Children
16. Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing/steroid-dependent nephrotic syndrome
17. The genetic landscape and clinical spectrum of nephronophthisis and related ciliopathies
18. Cystinosis
19. Autoantibodies Targeting Nephrin in Podocytopathies
20. #2245 ECYSCO, a European cystinosis cohort
21. Preventing Relapses in Childhood Nephrotic Syndrome
22. Nlrp2 deletion ameliorates kidney damage in a mouse model of cystinosis
23. A novel flow cytometry panel to identify prognostic markers for steroid-sensitive forms of idiopathic nephrotic syndrome in childhood
24. Primary hyperoxaluria in Italy: the past 30 years and the near future of a (not so) rare disease
25. Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency
26. Variation of the clinical spectrum and genotype-phenotype associations in Coenzyme Q10 deficiency associated glomerulopathy
27. Improving knowledge on safe medication management of inpatient children and adolescents: a pre-post study
28. Update on the treatment of steroid-sensitive nephrotic syndrome
29. Circulating plasmablasts in children with steroid-sensitive nephrotic syndrome
30. Belimumab for the treatment of children with frequently relapsing nephrotic syndrome: the BELNEPH study
31. Distal renal tubular acidosis: a systematic approach from diagnosis to treatment
32. Cystinosis
33. Refining genotype–phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants
34. Updating the International IgA Nephropathy Prediction Tool for use in children
35. IgM on the surface of T cells: a novel biomarker of pediatric-onset systemic lupus erythematosus
36. Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders
37. Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in children
38. An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis
39. Semaphorin 3B–associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients
40. Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis.
41. A New and Rapid LC-MS/MS Method for the Determination of Cysteamine Plasma Levels in Cystinosis Patients.
42. Induced pluripotent stem cell-based disease modeling identifies ligand-induced decay of megalin as a cause of Donnai-Barrow syndrome
43. The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results
44. Cystinosis
45. Pediatric Fanconi Syndrome
46. Renal Manifestations of Metabolic Disorders in Children
47. Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis
48. International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people
49. Intrinsic Bone Defects in Cystinotic Mice
50. Autologous Mesenchymal Stromal Cell Therapy for Idiopathic Nephrotic Syndrome: The MESNEPH Study: PUB225
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.